Maximum standardized uptake value change rate before and after neoadjuvant chemotherapy can predict early recurrence in patients with locally advanced esophageal cancer: a multi-institutional cohort study of 220 patients in Japan.
Kentaro MurakamiNaoya YoshidaYusuke TaniyamaKozue TakahashiTakeshi ToyozumiTakashi UnoTakashi KameiHideo BabaHisahiro MatsubaraPublished in: Esophagus : official journal of the Japan Esophageal Society (2022)
before and after NAC is clinically useful as it could help predict TRG, survival outcome, and early recurrence within 6 months post esophagectomy and is easily obtainable in general clinical practice. We believe that it may also help determine suitable treatment strategies for LAEC.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- rectal cancer
- clinical practice
- free survival
- squamous cell carcinoma
- lymph node
- sentinel lymph node
- ejection fraction
- chronic kidney disease
- radiation therapy
- peritoneal dialysis
- transcription factor
- prognostic factors
- clinical trial
- patient reported outcomes
- minimally invasive